Keywords
How to Cite
Abstract
DOAC represent an evolution for oral anticoagulation in the prevention of venous thromboembolism in major orthopaedic surgery of the limbs, the treatment of the different phases of deep vein thrombosis and pulmonary embolism and the stroke prevention in non-valvular atrial fibrillation. This paper is aimed to dissect the different aspects to consider at the election of the antithrombotic agents, according to several clinical and socio-economical aspects leading to a better individualization of the treatment, and to provide useful resources for the practicing physician and his patients.
References
2. Lauffenburger JC, Farley JF, Gehi AK et al. Factors driving anticoagulant selection in patients with atrial fibrillation in the United States. Am J Cardiol. 2015; 115: 1095-1101.
3. Sardar P, Chatterjee S, Chaudhari S, Lyp GYH. New oral anticoagulants in elderly adults: Evidence from a meta-analysis of randomized trials. J Am Geriatr Soc. 2014; 62: 857-864.
4. Nutescu EA. Pharmacoeconomic implications of thromboprophylaxis with new oral anticoagulants after total hip or knee replacement in the USA. Expert Opin Pharmacother. 2013; 14:
525-534.
5. Amin A, Bruno A, Trocio J, Lin J, Lingohr Smith M. Real-world medical cost avoidance when new oral anticoagulants are used versus warfarin for venous thromboembolism in the United
States. Clin Appl Thromb/Hemost. 2016; 22: 5-11.
6. http://af.garfieldregistry.org/. Datos a Junio 2017.
7. Harrington AR, Armstrong EP, Nolan PE Jr, Malone DC. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation. Stroke.
2013;44(6):1676-1681.
8. Deitelzweig S, Amin A, Jing Y, et al. Medical costs of oral anticoagulants vs warfarin for atrial fibrillation patients with different stroke risks. Cardiol Ther. 2013; 2: 165-170.
9. Lip GY, Kongnakorn T, Phatak H, Kuznik A, Lanitis T et al. Cost effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation. Clin Ther. 2014; 36: 192-210.
10. Vedovati, MC, Verdecchia P, Giustozzi M et al. Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation. Int J Cardiol.
2017; 236: 363-369.
11. Chatterjee S, Sardar P, Giri JS, Ghosh J, Mukherjee D. Treatment discontinuations with new oral agents for long-term anticoagulation: Insights from a meta-analysis of 18 randomized
trials including 101,801 patients. Mayo Clin Proc. 2014; 89: 896-907.
12. Hernandez Madrid A, Potpara TS, Dagres N et al. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe:
result of a self-assessment patient survey conducted by the European Heart Rhythm Association. Europace. 2016; 18: 463-467.
13. Amara W, Larsen TB, Sciaraffia E et al. Patients’ attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association. Europace. 2016; 18: 151-156.
14. www.Afibmaters.org. Website for patients
15. Heidbuchel H, Verhamme P, Alings M et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015; 17, 1467-1507.
16. Recomendaciones para el manejo de la terapeutica anticoagulante en el perioperatorio y procedimientos invasivos. Guias de diagnostico y tratamiento SAH 2017; 281-288
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar